• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Allergan

Allergan

Allergan PLC AGN 4 Star

Last Price$299.25Day Change (%)-2.40%
Open Price$302.81Day Change ($)-7.35
Day Range298.15–305.8852-Week Range201.91–317.72

As of Mon 6/29/2015 7:32:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. KYTH INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of KYTHERA Biopharmaceuticals, Inc. Concerning the Sale of the Company to Allergan plc

    KYTH INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of KYTHERA Biopharmaceuticals, Inc. Concerning the Sale of the Company to Allergan plc

  2. EQUITY ALERT: The Rosen Law Firm Announces Investigation of Kythera Biopharmaceuticals Inc. Concerning Its Proposed Sale to Allergan plc - KYTH

    EQUITY ALERT: The Rosen Law Firm Announces Investigation of Kythera Biopharmaceuticals Inc. Concerning Its Proposed Sale to Allergan plc - KYTH

  3. KYTHERA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of KYTHERA Biopharmaceuticals, Inc. (KYTH) Over the Proposed Sale of the Company to Allergan plc.

    KYTHERA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of KYTHERA Biopharmaceuticals, Inc. (KYTH) Over the Proposed Sale of the Company to Allergan plc.

  4. Actavis plc is now Allergan plc

    Actavis plc is now Allergan plc

  5. Allergan to buy double-chin treatment maker Kythera for $2.1 billion

    Allergan to buy double-chin treatment maker Kythera for $2.1 billion

  6. Richter And Allergan Announce FDA Has Extended The Review Period For Cariprazine To September 2015

    Richter And Allergan Announce FDA Has Extended The Review Period For Cariprazine To September 2015

  7. Actavis Changes Name to Allergan After Deal For Botox Maker

    Actavis Changes Name to Allergan After Deal For Botox Maker

  8. Research and Markets: Macular Edema Pipeline Review, H1 2015 - 7 Companies & 9 Drug Profiles

    Research and Markets: Macular Edema Pipeline Review, H1 2015 - 7 Companies & 9 Drug Profiles

  9. KYTHERA BIOPHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

    KYTHERA BIOPHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

  10. Investor Alert: Peiffer Rosca Wolf Law Firm Investigating Whether Proposed Sale of KYTHERA Biopharmaceuticals, Inc. Is in Shareholders’ Best Interest

    Investor Alert: Peiffer Rosca Wolf Law Firm Investigating Whether Proposed Sale of KYTHERA Biopharmaceuticals, Inc. Is in Shareholders’ Best Interest

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.